Recent Company News

• 04:30 AM ET Jul 11, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 03:05 AM ET Jul 21, 2025
  

  Xvivo Perfusion enrols first patient in US PRESERVE CAP study for its Heart Assist Transport device (SEK 213.60, +1.20)

• 12:57 AM ET Jul 14, 2025
  

  Xvivo Perfusion upgraded to buy from hold at DNB Carnegie (SEK 201.40, 0.00)

• 08:00 PM ET Jul 11, 2025
  

  StreetAccount Sector Summary - Healthcare Weekly Recap

• 03:54 AM ET Jul 11, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (71 total)

• 01:40 AM ET Jul 11, 2025
  

  Xvivo Perfusion reports Q2 EPS SEK0.05 vs FactSet SEK0.62 [3 est, SEK0.50-0.72] (SEK 299.20, 0.00)

• 02:23 AM ET Apr 29, 2025
  

  Xvivo Perfusion announces 12-month follow-up results from European multicenter heart trial, NIHP2019, was presented at the 2025 ISHLT Annual Meeting in Boston, USA (SEK 300.00, 0.00)

• 02:55 AM ET Apr 25, 2025
  

  Xvivo Perfusion upgraded to hold from sell at Danske Bank (SEK 313.80, 0.00)